View Post

More Data Needed on Tissue-Agnostic Therapy Use in Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Emily Brill From: ajmc.com A new report suggests that much remains to be seen about tissue-agnostic therapies’ effectiveness for treating breast cancer, as “a paucity of data” exists regarding this relatively new treatment’s impact on the disease, and that additional studies are needed to evaluate how well these therapies work on treating metastatic breast cancer (mBC). The investigators reviewed …

View Post

Here’s Why BMI May Not Be the Best Indicator of Breast Cancer Outcomes

In In The News by Barbara Jacoby

By: Antonia DePace From: curetoday.com Determining body composition – a more nuanced approach to predicting survival outcomes in patients with breast cancer – may be a more accurate indicator than BMI, according to one study. Body composition may be more important than body mass index (BMI) when it comes to predicting the impact that weight has on overall survival outcomes …

View Post

Trodelvy Improves QOL in Triple-Negative Breast Cancer

In In The News by Barbara Jacoby

By: Greg Laub From: medpagetoday.com At the European Society for Medical Oncology (ESMO) virtual meeting, new data from the phase III ASCENT study was presented showing that patients with treatment-resistant metastatic triple-negative breast cancer (TNBC) who received sacituzumab govitecan (Trodelvy) had significant and clinically meaningful improvements in health-related quality of life (QOL). In this exclusive MedPage Today video, co-investigator Kevin …

View Post

Breast Cancer Treatments Propel Many Women Into ‘Rapid, Dramatic’ Medical Menopause

In In The News by Barbara Jacoby

By: Katie Kosko From: curetoday.com Some breast cancer therapies and surgeries cause a reduction in estrogen levels, forcing many women immediately into menopause. In October 2011, Kristen Wiley found a pea-sized lump in her breast. Having had a clear mammogram just seven months earlier, she thought it would go away. When the lumps were still there in December, Wiley decided …

View Post

Researchers Discover New Molecule That Eliminates Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Ty & Charlene Bollinger From: thetruthaboutcancer.com Each year, over 250,000 women (and nearly 2500 men) are diagnosed with breast cancer in the United States. 1 in 8 women will be diagnosed with invasive breast cancer in their lifetime. Approximately three-quarters of cases are a type called estrogen receptor-positive, in which the cancer cells have a receptor in their membranes …

View Post

Smart microscope slides make breast cancer cells leap off screen

In In The News by Barbara Jacoby

By: Kristin Houser From: freethink.com On a new smart microscope slide, breast cancer cells appear brightly colored — and that could make it easier for doctors to correctly diagnose patients when their disease is in its earliest stages, and treatments are most effective. “Comparing images from our slides to conventional staining is like watching color television when all you’ve seen …

View Post

Investigators Combine Zanidatamab With Evorpacept to Potentially Improve Outcomes in HER2-Expressing Breast Cancer

In Clinical Studies News by Barbara Jacoby

By: Nichole Tucker From: targetedonc.com Zanidatamab in combination with evorpacept has been dosed for the first time in a patient with HER2-low breast cancer. The first patient has been dosed with the combination of zanidatamab and evorpacept (ALX148) in a phase 1b/2 study evaluating the safety and efficacy of the combination in HER2-low breast cancer, and additional non-breast HER2-expressing solid …

View Post

What to know about the CA 15-3 test and breast cancer

In In The News by Barbara Jacoby

From: medicalnewstoday.com The cancer antigen 15-3 (CA 15-3) test is a blood test that can indicate how a person is responding to treatment for invasive breast cancer or check for the recurrence of breast cancer. Healthy cells in the breast release a protein called CA 15-3. When a person has breast cancer, cancerous cells or tumors in the breast can …

View Post

Rare Patient Voice: Study Opportunity for Breast Cancer Female Patients

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: 60 minute Web-Assisted Phone Interview Compensation $200 Now accepting Residents from ALL Countries!! * Companies have finally realized the REAL EXPERTS are the Patients and Caregivers! * Better products, services, and treatments, Start with Better Research. They need YOUR input and are willing to pay $100 an hour for it! Signup Today and let YOUR Voice be heard! Why …